Serum Mac-2 binding protein glycosylation isomer dynamics in patients achieving sustained virologic response for hepatitis C virus.

Yu-Ping ChangChen-Hua LiuChiuan-Bo HuangJi-Yuh LeeChun-Jen Liu Tung-Hung SuShang-Chin HuangTai-Chung TsengPei-Jer Chen Jia-Horng Kao

Published in: Journal of gastroenterology and hepatology (2024)

Serum M2BPGi is a reliable marker for advanced hepatic fibrosis. Following viral clearance, there is a notable M2BPGi decrease, with the extent of reduction influenced by ALT levels and fibrosis stage.

Keyphrases

hepatitis c virus
end stage renal disease
binding protein
newly diagnosed
chronic kidney disease
ejection fraction
sars cov
human immunodeficiency virus
peritoneal dialysis
hiv infected
antiretroviral therapy
liver fibrosis